Related Experiment Video
Updated: Aug 25, 2025

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
The Cancer Hub Approach for Upper Gastrointestinal Surgery During COVID-19 Pandemic: Outcomes from a UK Cancer Centre
Joseph P Doyle1,2, Pranav H Patel1,2, Sophie L F Doran1
1Department of Surgery, The Royal Marsden Hospital, London, UK.
Insights
The RM Partners Cancer Hub safely continued upper gastrointestinal cancer surgeries during the COVID-19 pandemic. This approach ensured continued patient care with good survival outcomes despite healthcare disruptions.
Area of Science:
- Oncology
- Surgical Oncology
- Public Health
Background:
- The COVID-19 pandemic significantly disrupted global healthcare, leading to widespread cancellations of elective surgeries in England.
- To maintain cancer care, the Royal Marsden Hospital established the 'RM Partners Cancer Hub' to provide a 'COVID-lite' surgical environment.
- This initiative aimed to mitigate the impact of the pandemic on essential oncological treatments.
Purpose of the Study:
- To describe the operational setup of the RM Partners Cancer Hub.
- To evaluate the outcomes of upper gastrointestinal (UGI) cancer resections performed within this specialized setting.
- To assess the safety and efficacy of continuing complex cancer surgery during a public health crisis.
Main Methods:
- The RM Partners Cancer Hub operated from April 2020 to April 2021, coordinating resources across the RM Partners West London Cancer Alliance.
- A prioritized surgical case strategy was implemented for UGI cancers.
- Strict infection control protocols and pre-operative screening for COVID-19 were rigorously applied.
Main Results:
- A total of 231 patients with confirmed or suspected UGI cancer underwent surgery, with 213 successful resections.
- The combined 90-day mortality rate was 3.5%.
- Excellent 2-year disease-free survival (DFS) and overall survival (OS) rates were observed for esophageal, gastric, and pancreatic cancer resections, with one patient recovering fully from perioperative COVID-19.
Conclusions:
- The RM Partners Cancer Hub model proved to be a safe and effective strategy for delivering UGI cancer resectional surgery.
- This approach facilitated the continuation of vital cancer care during periods of significant healthcare service disruption.
- The study highlights the feasibility of maintaining specialized oncological surgery amidst global health crises.
Background:
The coronavirus disease 2019 (COVID-19) pandemic caused unprecedented disruption to global healthcare delivery. In England, the majority of elective surgery was postponed or cancelled to increase intensive care capacity. Our unit instituted the 'RM Partners Cancer Hub' at the Royal Marsden Hospital in London, to deliver ongoing cancer surgery in a 'COVID-lite' setting. This article describes the operational set-up and outcomes for upper gastrointestinal (UGI) cancer resections performed during this period.
Methods:
From April 2020 to April 2021, the Royal Marsden Hospital formed the RM Partners Cancer Hub. This approach was designed to coordinate resources and provide as much oncological treatment as feasible for patients across the RM Partners West London Cancer Alliance. A UGI surgical case prioritisation strategy, along with strict infection control pathways and pre-operative screening protocols, was adopted.
Results:
A total of 231 patients underwent surgery for confirmed or suspected UGI cancer during the RM Partners Cancer Hub, with 213 completed resections and combined 90-day mortality rate of 3.5%. Good short-term survival outcomes were demonstrated with 2-year disease free survival (DFS) and overall survival (OS) for oesophageal (70.8% and 72.9%), gastric (66.7% and 83.3%) and pancreatic cancer resections (68.0% and 88.0%). One patient who developed perioperative COVID-19 during the RM Partners Cancer Hub operation made a full recovery with no lasting clinical sequelae.
Conclusion:
Our experience demonstrates that the RM Partners Cancer Hub approach is a safe strategy for continuing upper gastrointestinal (GI) resectional surgery during future periods of healthcare service disruption.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Cancer Survival Analysis
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

